OCT 01, 2020 8:15 AM PDT

HPV Vaccine Protects Against Cervical Cancer, Large Study Finds

WRITTEN BY: Annie Lennon

It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and cervical pre-cancer. However, from a large-scale study, researchers have now shown that the vaccine can also prevent invasive cervical cancer, the most severe form of the disease. 

“This is the first time that we, on a population level, are able to show that HPV vaccination is protective not only against cellular changes that can be precursors to cervical cancer but also against actual invasive cervical cancer,” says Jiayao Lei, a researcher at Karolinska Institutet in Sweden and an author of the study. 

“It is something we have long suspected but that we are now able to show in a large national study linking HPV vaccination and development of cervical cancer at the individual level.”

For the study, the researchers followed close to 1.7 million women aged between 10 and 30 for 11 years. Among the women, over 500,000 were vaccinated against HPV before the age of 17. 

In the end, they found that while 19 vaccinated women were diagnosed with cervical cancer within the period, 538 unvaccinated women were also diagnosed. This equals out to 47 and 94 diagnoses per 100,000 women, thus showing that the HPV vaccine is likely protective against the condition. 

In particular, the researchers found that HPV vaccination reduced the risk of developing cervical cancer by 88% among those vaccinated before the age of 17, and by around 50% if vaccinated between the ages of 17 and 30. 

They say that the discrepancy in effectiveness may be because girls under the age of 17 are less likely to have been exposed to the HPV infection and that the HPV vaccination has no therapeutic effect against a pre-existing infection. 

As such, the researchers conclude that their study shows that HPV vaccination may significantly reduce one’s risk of developing cervical cancer. They thus recommend that HPV vaccinations continue to be given to children and adolescents via national vaccination programs. 

 

Sources: Technology NetworksNBC

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
FEB 22, 2022
Cancer
What's Killing My Cell Cultures? Troubleshooting Cell Growth Issues
FEB 22, 2022
What's Killing My Cell Cultures? Troubleshooting Cell Growth Issues
Nothing's more maddening than cells that won't grow or cell cultures that won't attach. Stunted cell growth and erratic ...
MAR 14, 2022
Cancer
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
MAR 14, 2022
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
Over the past decade, immunotherapy drugs known as immune checkpoint inhibitors have emerged as a promising an ...
MAR 24, 2022
Cardiology
A New Drug Effectively Treats Obesity
MAR 24, 2022
A New Drug Effectively Treats Obesity
Semaglutide has been called a "gamechanger" for treating obesity in adults.
MAR 28, 2022
Cancer
FDA Encourages Inclusion of More Older Adults in Cancer Clinical Trials
MAR 28, 2022
FDA Encourages Inclusion of More Older Adults in Cancer Clinical Trials
While cancer is a disease that inflicts people of all ages, it is often considered a disease of old age. The science to ...
APR 26, 2022
Immunology
Unraveling the Mystery of an Immune Cell Checkpoint
APR 26, 2022
Unraveling the Mystery of an Immune Cell Checkpoint
The immune system can get tired when it has to fight against a chronic infection or a disease like cancer. Exhausted T c ...
MAY 13, 2022
Drug Discovery & Development
Promising New Treatment for Cat Litter Parasite T. Gondii
MAY 13, 2022
Promising New Treatment for Cat Litter Parasite T. Gondii
Researchers have discovered a promising therapy for those suffering from toxoplasmosis, a disease caused by a parasite l ...
Loading Comments...